SENSEI BIOTHERAPEUTICS INC (SNSE) Stock Analyst Earnings Estimates
NASDAQ:SNSE - Nasdaq - US81728A2078 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A 270.65% | N/A 126.82% | N/A 75.09% | ||||||||
| EBITDA YoY % growth | -12.7M | -12.36M 2.68% | -18.51M -49.76% | -36.8M -98.81% | -48.84M -32.72% | -35.713M 26.88% | -30.341M 15.04% | N/A -5.05% | N/A -7.81% | N/A -34.47% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -12.74M | -12.43M 2.43% | -18.72M -50.60% | -37.49M -100.27% | -50.19M -33.88% | -37.064M 26.15% | -31.663M 14.57% | N/A 3.24% | N/A -11.86% | N/A -30.26% | N/A -23.40% | N/A 24.49% | N/A 73.97% | N/A 391.68% | N/A 177.26% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -27.20 71.39% | -31.60 -16.18% | -24.40 22.78% | -24.00 1.64% | N/A 9.59% | N/A 28.31% | N/A -40.39% | N/A 16.86% | N/A 26.97% | N/A 83.08% | N/A 572.73% | N/A 130.77% |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|
| EPS Q2Q % growth | -5.71 -2.00% | -5.75 0.81% | -5.85 5.65% |
| Revenue Q2Q % growth | |||
| EBITDA Q2Q % growth | -8.568M -20.20% | -9.18M -34.37% | -10.506M -75.07% |
| EBIT Q2Q % growth | -7.197M 7.58% | -6.837M 12.60% | -6.359M 13.17% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | -5.40 15.63% | -4.56 | -0.84 | -18.53% |
| Q4 2024 Q2Q % growth | -6.20 -3.33% | -5.64 | -0.56 | -9.85% |
| Q3 2024 Q2Q % growth | -5.80 -3.57% | -6.38 | 0.58 | 9.02% |
| Q2 2024 Q2Q % growth | -5.60 9.68% | -5.89 | 0.29 | 4.85% |
| Q1 2024 Q2Q % growth | -6.40 3.03% | -5.61 | -0.79 | -14.08% |
| Q4 2023 Q2Q % growth | -6.00 25.00% | -6.28 | 0.28 | 4.40% |
| Q3 2023 Q2Q % growth | -5.60 36.36% | -6.92 | 1.32 | 19.02% |
| Q2 2023 Q2Q % growth | -6.20 8.82% | -6.74 | 0.54 | 8.04% |
| Q1 2023 Q2Q % growth | -6.60 17.50% | -7.26 | 0.66 | 9.12% |
| Q4 2022 Q2Q % growth | -8.00 -33.33% | -8.16 | 0.16 | 1.96% |
| Q3 2022 Q2Q % growth | -8.80 -37.50% | -7.55 | -1.25 | -16.59% |
| Q2 2022 Q2Q % growth | -6.80 -6.25% | -8.06 | 1.26 | 15.61% |
| Q1 2022 Q2Q % growth | -8.00 4.76% | -7.14 | -0.86 | -12.04% |
| Q4 2021 Q2Q % growth | -6.00 88.93% | -6.94 | 0.94 | 13.49% |
| Q3 2021 Q2Q % growth | -6.40 | -4.95 | -1.45 | -29.37% |
| Q2 2021 Q2Q % growth | -6.40 | -5.92 | -0.48 | -8.06% |
| Q1 2021 Q2Q % growth | -8.40 | -6.20 | -2.20 | -35.45% |
| Q4 2020 Q2Q % growth | -54.20 | -60.38 | 6.18 | 10.24% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -3400% | 0% | -2744.03% |
| Revenue | N/A | N/A | N/A | N/A |